News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chia-Tai Tianqing Files IND For Biotech Product Licensed From Alphamab


6/18/2014 1:48:14 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Chia-Tai Tianqing Pharma Group (CTTQ), a diversified China drug company headquartered in Jiangsu province, filed an IND with the CFDA to begin clinical trials of its Recombinant Human Coagulation Factor VIII (rhFVIII). CTTQ in-licensed rights to the product from Alphamab, a biotech located in Suzhou’s BioBay Park. The two companies have been collaborating on developing the product since 2010.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES